{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-015543","form_type":"8-K","ticker":"EUDA","cik":"0001847846","company_name":"EUDA Health Holdings Ltd","filed_at":"2022-06-01T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.811033+00:00","generated_at":"2026-06-25T05:36:24.680553+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"8i Acquisition 2 extends due diligence for EUDA Health combination to June 15, 2022","bullets":["Parties amended the Share Purchase Agreement on May 30, 2022.","Due diligence review period extended from May 31, 2022 to June 15, 2022.","Amendment involves LAX, EUDA Health, Watermark Developments, and representative Kwong Yeow Liew.","Business combination to be effected through purchase of all EUDA Health shares by LAX."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-015543","json":"https://secwatch.observer/filing/0001493152-22-015543.json","markdown":"https://secwatch.observer/filing/0001493152-22-015543.md","text":"https://secwatch.observer/filing/0001493152-22-015543.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1847846/000149315222015543/0001493152-22-015543-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1847846/000149315222015543/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T05:36:24.680553+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}